CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab (CYDY)

VANCOUVER, Washington, March 08, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing

Read more

Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020

MIRAMAR, Fla., July 27, 2020 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the FDA has

Read more

Featured Interview: President Damon Mintz of Innovest Global, Inc. (OTCPink: IVST)

President Damon Mintz of Innovest Global, Inc., talks about being a diversified company, with quality holdings in multiple industries, and plans for growing shareholder value in 2019.

Read more

SANUWAVE Health, Inc., CEO Kevin Richardson Returns to Uptick Newswire’s “Stock Day” with Everett Jolly to Discuss Recent Accomplishments

Phoenix, AZ (Uptick Newswire – February 21, 2018) –  SANUWAVE Health, Inc. (OTCQB: SNWV) (“the Company”), today announced CEO Kevin Richardson’s

Read more

Pressure BioSciences, Inc. and ISS, Inc. Announce Two-Year Worldwide Co-Marketing and Distribution Agreement

ISS High Pressure Optical Cell Integrated with PBI Automated High Pressure Instrument: Combination Results in Unique Analytical System with Potential to Significantly

Read more